There are a few hurdles in your way, but the price may be worth it.
Researchers from New England Biolabs (NEB®) and Yale University describe the first fully synthetic bacteriophage engineering ...
A health informatician and general medicine and surgery by profession, Dr Muragijimana said he came up with the idea of the ...
Backed with $82 million and led by two of BioMarin’s former executives, Mendra plans to acquire rare disease assets and use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results